These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38326576)
1. Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study. Hajiyev K; Henkes H; Khanafer A; Bücke P; Hennersdorf F; Bäzner H; von Gottberg P Cardiovasc Intervent Radiol; 2024 Mar; 47(3):291-298. PubMed ID: 38326576 [TBL] [Abstract][Full Text] [Related]
2. Treatment of In-stent Restenosis of the Internal Carotid Artery Using Drug-eluting Balloons. Marton A; Blényesi E; Török K; Balogh G; Gubucz I; Nardai S; Lenzsér G; Nagy C; Bajzik G; Tollár J; Repa I; Nagy F; Vajda Z Clin Neuroradiol; 2024 Mar; 34(1):147-154. PubMed ID: 37676281 [TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis. Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315 [TBL] [Abstract][Full Text] [Related]
4. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis. de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071 [TBL] [Abstract][Full Text] [Related]
5. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes. Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169 [TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis. Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705 [TBL] [Abstract][Full Text] [Related]
7. Drug-Coated Balloon Angioplasty for Carotid Artery In-Stent Restenosis: Case Series. Eljack A; Shih E; Meidan T; Lanfear A; Taha M; Sayfo S; Gable D; Potluri S J Endovasc Ther; 2024 Apr; 31(2):305-311. PubMed ID: 36154316 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials. Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486 [TBL] [Abstract][Full Text] [Related]
9. Management of in-sent restenosis after carotid artery stenting in high-risk patients. Zhou W; Lin PH; Bush RL; Peden EK; Guerrero MA; Kougias P; Lumsden AB J Vasc Surg; 2006 Feb; 43(2):305-12. PubMed ID: 16476606 [TBL] [Abstract][Full Text] [Related]
10. Treatment and Predictors of Recurrent Internal Carotid Artery In-Stent Restenosis. Mihály Z; Vértes M; Entz L; Dósa E Vasc Endovascular Surg; 2021 May; 55(4):374-381. PubMed ID: 33563130 [TBL] [Abstract][Full Text] [Related]
11. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial. Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B; JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665 [TBL] [Abstract][Full Text] [Related]
13. A Randomized Comparison of 2 Different Drug-Coated Balloons for In-Stent Restenosis. Liu S; Zhou Y; Shen Z; Chen H; Qiu C; Fu G; Li H; Yu Z; Zeng Q; Li Z; Li W; Qiao S; JACC Cardiovasc Interv; 2023 Apr; 16(7):759-767. PubMed ID: 37045496 [TBL] [Abstract][Full Text] [Related]
14. Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting. Li J; Hua Y; Needleman L; Forsberg F; Eisenbray JR; Li Z; Liu R; Tian X; Jiao L; Liu JB J Neurointerv Surg; 2019 Jun; 11(6):574-578. PubMed ID: 30337379 [TBL] [Abstract][Full Text] [Related]
15. Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis. Clever YP; Cremers B; von Scheidt W; Böhm M; Speck U; Scheller B Clin Res Cardiol; 2014 Jan; 103(1):21-7. PubMed ID: 24072418 [TBL] [Abstract][Full Text] [Related]
16. Cutting Balloon Combined with Drug-Coated Balloon Angioplasty for the Treatment of In-Stent Restenosis. Zheng YC; Lee WC; Fang HY; Chen CJ; Yang CH; Wu CJ; Fang CY Int Heart J; 2021 Nov; 62(6):1213-1220. PubMed ID: 34744147 [TBL] [Abstract][Full Text] [Related]
17. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274 [TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials. Peng N; Liu W; Li Z; Wei J; Chen X; Wang W; Lin H Cardiovasc Ther; 2020; 2020():1042329. PubMed ID: 32411298 [TBL] [Abstract][Full Text] [Related]